| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000011974 |
| Receipt No. | R000013987 |
| Official scientific title of the study | The significance of the state of muscularis mucosae (MM grade) as a new risk factor for nodal metastasis in considering the indication for additional surgical colectomy with lymph node dissection among submucosal-invasive (T1) colorectal carcinomas after endoscopic treatment |
| Date of disclosure of the study information | 2013/10/07 |
| Last modified on | 2016/04/09 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | The significance of the state of muscularis mucosae (MM grade) as a new risk factor for nodal metastasis in considering the indication for additional surgical colectomy with lymph node dissection among submucosal-invasive (T1) colorectal carcinomas after endoscopic treatment | |
| Title of the study (Brief title) | The significance of the state of muscularis mucosae (MM grade) as a risk factor for nodal metastasis in considering the indication for additional surgical colectomy among T1 colorectal carcinomas after endoscopic treatment | |
| Region |
|
|
| Condition | |||||
| Condition | Colorectal carcinomas | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | The aim is to confirm the significance of the state of muscularis mucosae (MM grade) as a new risk factor for nodal metastasis, to clarify pathological risk factors for lymph node metastasis of T1 colorectal cancers, and to establish the indication for additional surgical colectomy with nodal dissection after endoscopic treatment. |
| Basic objectives2 | Others |
| Basic objectives -Others | Retrospective study |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | To clarify pathological risk factors for lymph node metastasis of T1 colorectal cancers, confirming the significance of the state of muscularis mucosae (MM grade). |
| Key secondary outcomes | To establish the indication for additional surgical colectomy with lymph node dissection, based on the pathological risk factors of the excised specimen after endoscopic treatment. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | A total of more than 20000 colorectal neoplasms excluding advanced cancers have been resected endoscopically or surgically at Showa University Northern Yokohama Hospital from 2001 to 2013. Of these, approximately 800 T1 colorectal cancers were included. | |||
| Key exclusion criteria | People not grown up | |||
| Target sample size | 800 | |||
| Research contact person | |
| Name of lead principal investigator | Hideyuki Miyachi |
| Organization | Showa University Northern Yokohama Hospital |
| Division name | Digestive Disease Center |
| Address | 35-1 Chigasaki Chuo, Tsuzuki-ku, Yokohama 224-8503, Japan |
| TEL | 045-949-7265 |
| miyachi@med.showa-u.ac.jp | |
| Public contact | |
| Name of contact person | Hideyuki Miyachi |
| Organization | Showa University Northern Yokohama Hospital |
| Division name | Digestive Disease Center |
| Address | 35-1 Chigasaki Chuo, Tsuzuki-ku, Yokohama 224-8503, Japan |
| TEL | 045-949-7265 |
| Homepage URL | |
| miyachi@med.showa-u.ac.jp | |
| Sponsor | |
| Institute | Showa University Northern Yokohama Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Digestive Disease Center, Showa University Northern Yokohama Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | Results:
MM grade was associated with nodal metastasis (p = 0.026), and no patients with MM grade 1 lesions had nodal metastasis. Significant risk factors for nodal metastasis in patients with MM grade 2 lesions were attribution of female (p = 0.006), lymphovascular infiltration (p < 0.001), tumor budding (p = 0.045), and poorly differentiated adenocarcinoma or mucinous carcinoma (p = 0.007). Nodal metastasis occurred in 1.06% of lesions without any of these pathological factors, but in 10.3% and 20.1% of lesions with at least one factor in male and female patients, respectively. There was good inter-observer agreement for MM grade evaluation, with a kappa value of 0.67. Conclusions: Stratification using MM grade, pathological factors and patient sex provided more appropriate indication for additional surgery with lymph node dissection after endoscopic treatment for T1 colorectal carcinomas. |
| Other related information | Background and Aim:
Recent advances in endoscopic technology have allowed many T1 colorectal carcinomas to be resected endoscopically with negative margins. However, the criteria for curative endoscopic resection remain unclear. We aimed to identify risk factors for nodal metastasis in T1 carcinoma patients and hence establish the indication for additional surgery with lymph node dissection. Methods: Initial or additional surgery with nodal dissection was performed in 653 T1 carcinoma cases. Clinicopathological factors were retrospectively analyzed with respect to nodal metastasis. The status of the muscularis mucosae (MM grade) was defined as grade 1 (maintenance) or grade 2 (fragmentation or disappearance). The lesions were then stratified based on the risk of nodal metastasis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000013987 |